Cargando…

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity

Detalles Bibliográficos
Autores principales:	Konstantinidou, Georgia, Rimessi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188944/ https://www.ncbi.nlm.nih.gov/pubmed/32391272 http://dx.doi.org/10.3389/fonc.2020.00588

Ejemplares similares

Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency
por: Ferreirós, Alba, et al.
Publicado: (2019)

Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence
por: Scaglioni, Pier Paolo, et al.
Publicado: (2012)

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
por: Maffeis, Valeria, et al.
Publicado: (2019)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Editorial: Cellular and Phenotypic Plasticity in Cancer
por: Ferrao, Petranel T., et al.
Publicado: (2015)

Editorial: Epigenetics and cellular plasticity in glioblastoma
por: Lo, Hui-Wen, et al.
Publicado: (2023)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Mitochondrial Ca(2+) Remodeling is a Prime Factor in Oncogenic Behavior
por: Rimessi, Alessandro, et al.
Publicado: (2015)

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
por: Roncarati, Roberta, et al.
Publicado: (2019)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

ZNF768 links oncogenic RAS to cellular senescence
por: Villot, Romain, et al.
Publicado: (2021)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Cellular Reprogramming—A Model for Melanoma Cellular Plasticity
por: Granados, Karol, et al.
Publicado: (2020)

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
por: Sun, Nai-Yun, et al.
Publicado: (2020)

Loss of PTEN-Induced Kinase 1 Regulates Oncogenic Ras-Driven Tumor Growth By Inhibiting Mitochondrial Fission
por: Zhu, Dantong, et al.
Publicado: (2022)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
por: Zhao, Yue, et al.
Publicado: (2023)

Editorial: Plastic Surgery for the Oncological Patient
por: Daigeler, Adrien
Publicado: (2016)

Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K
por: Pallegar, Nikitha K., et al.
Publicado: (2015)

Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015)

Developmental Plasticity and Cellular Reprogramming in Caenorhabditis elegans
por: Rothman, Joel, et al.
Publicado: (2019)

Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
por: Milan, Enrico, et al.
Publicado: (2023)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity
por: Huyghe, A., et al.
Publicado: (2022)

MAP17, a ROS-dependent oncogene
por: Carnero, Amancio
Publicado: (2012)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
por: Yang, Xiao, et al.
Publicado: (2018)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

MYC/MAX-Activated LINC00958 Promotes Lung Adenocarcinoma by Oncogenic Transcriptional Reprogramming Through HOXA1 Activation
por: Zhang, Tao, et al.
Publicado: (2022)

Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζ
por: Rimessi, Alessandro, et al.
Publicado: (2013)

Editorial: Reviews in molecular and cellular oncology
por: Bezerra, Daniel P., et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology
por: Ferrao, Petranel T., et al.
Publicado: (2023)

PRG3 induces Ras-dependent oncogenic cooperation in gliomas
por: Fan, Zheng, et al.
Publicado: (2016)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pgbpj2ldmpejgilf80f351f8v4